Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

Meletios A Dimopoulos; Athanasios K. Anagnostopoulos; Marie‐Christine Kyrtsonis; Konstantinos Zervas; Constantinos Tsatalas; Garyfallia Kokkinis; Panagiotis Repoussis; Argiris Symeonidis; Souzana Delimpasi; Eirini Katodritou; Elina Vervessou; Evridiki Michali; Anastasia Pouli; Dimitra Gika; Amalia Vassou; Evangelos Terpos; Nikolaos Anagnostopoulos; T. Economopoulos; Gerasimos Pangalis

doi:10.1200/jco.2007.10.9926

Related publications

Article2006

Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.

Meletios A Dimopoulos, Athanasios K. Anagnostopoulos, Marie Christine Kyrtsonis, Constantinos Tsatalas, Garyfallia Kokkini, Panagiotis P. Repoussis, Athanasios Zomas, Argiris Symeonidis, Evridiki Michali, Nikolaos Athanasios Anagnostopoulos, Evangelos Terpos, T. Economopoulos, Gerasimos Pangalis

Article2004

Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.

Meletios A Dimopoulos, Maria Christina Kyrtsonis, Constantinos Tsatalas, Garyfallia Kokkini, Panagiotis Repoussis, Athanasios Zomas, Argiris Symeonidis, Evridiki Michali, Athanasios K. Anagnostopoulos, Nikolaos Anagnostopoulos, T. Economopoulos, Gerasimos Pangalis

Article2012

Primary Treatment of Waldenstrom's Macroglobulinemia with Dexamethasone, Rituximab and Cyclophosphamide (DRC): Final Analysis of a Phase II Study

Meletios A Dimopoulos, Μαρία Ρούσσου, Efstathios Kastritis, Evdoxia Hadjiharissi, Marie‐Christine Kyrtsonis, Argiris Symeonidis, Panagiotis Repoussis, Eurydiki Michalis, Sosana Delimpasi, Konstantinos Tsatalas, Panagiotis Tsirigotis, Amalia Vassou, Elina Vervessou, Eirini Katodritou, Maria Gavriatopoulou, Dimitra Gika, Evangelos Terpos, Konstantinos Zervas

Article2009

Primary Treatment of Waldenstrom's Macroglobulinemia with Dexamethasone, Rituximab and Cyclophosphamide (DRC): Long Term Follow-up Analysis of a Phase II Study.

Meletios A Dimopoulos, Evdoxia Hadjiharissi, Marie‐Christine Kyrtsonis, Argiris Symeonidis, Panayiotis Repoussis, Eurydiki Michalis, Sosana Delimpasi, Costas Tsatalas, Panagiotis Tsirigotis, Amalia Vassou, Elina Vervessou, Eirini Katodritou, Maria Gavriatopoulou, Nikolaos Anagnostopoulos, Dimitra Gika, Evangelos Terpos, Konstantinos Zervas

Letter2015

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study

Efstathios Kastritis, Maria Gavriatopoulou, Marie‐Christine Kyrtsonis, Μαρία Ρούσσου, Evdoxia Hadjiharissi, Argiris Symeonidis, Panagiotis Repoussis, Evridiki Michalis, Sosana Delimpasi, Konstantinos Tsatalas, Panagiotis Tsirigotis, Amalia Vassou, Elina Vervessou, Eirini Katodritou, Dimitra Gika, Evangelos Terpos, Meletios A Dimopoulos

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

Abstract

Discussion(0)

Related publications

Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.

Primary Treatment of Waldenstrom’s Macroglobulinemia (WM) with Dexamethasone, Rituximab and Cyclophosphamide.

Primary Treatment of Waldenstrom's Macroglobulinemia with Dexamethasone, Rituximab and Cyclophosphamide (DRC): Final Analysis of a Phase II Study

Primary Treatment of Waldenstrom's Macroglobulinemia with Dexamethasone, Rituximab and Cyclophosphamide (DRC): Long Term Follow-up Analysis of a Phase II Study.

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study